Gilead Sciences Rallying Off Q1 Beat


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

''Gilead Sciences (NASDAQ: GILD) shares are trading higher by $3.81 at $104.32 in Friday's session. The catalyst for the rally is Q! beat for EPS ($2.94 vs. Est. $2.32) and for revenue ($7.59B vs. Est. $6.92B).In addition the company boosted guidance for the remainder of the year, the company now expects net product sales of $28 billion to $29 billion, versus its prior forecast of $26 billion to $27 billion.After a higher open ($103.20 vs. Thursday's close ($100.51), it retreated to $102.50 before resuming its rally. So far, it has breached the pair just below the $104 level, reaching $104.27. If the rally continues there be additional resistance at Monday's high ($104.53) and additional resistance at the series of highs at the %105.50 level from late April.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: TechnicalsIntraday UpdateMoversTrading IdeasPre-market outlook